<DOC>
	<DOCNO>NCT01274520</DOCNO>
	<brief_summary>This study compare technique continuous circulation liver mean prevent liver damage transportation transplant hospital . This new technique Machine Perfusion ( MP ) compare standard technique liver maintain bag solution ice without circulation . The investigator evaluate compare outcome transplant new technique standard technique . There 24 MP patient 's study . The investigator previously use technique success 20 human liver transplant patient . The investigator think benefit term less damage well function donor liver result fast recovery patient . This protective effect may allow u successfully transplant patient prevent people die wait liver transplant .</brief_summary>
	<brief_title>Hypothermic Machine Preservation-Phase 2</brief_title>
	<detailed_description>It hypothesis liver machine perfusion increase safe utilization exist supply extend criterion donor ( ECD ) liver ( 1 ) increase quality duration preservation thereby reduce clinical effect reperfusion injury ( 2 ) improve early outcome patient receive ECD liver allograft ( 3 ) develop reliable marker pretransplant assessment potential graft ( 4 ) give surgeon confidence transplant ECD liver ( 5 ) allow avenue ex vivo manipulation liver protect restore transiently injure liver . The propose study match cohort design . Potential subject recruit CLDT active Liver Transplant Waiting List . The Principal Investigator well CoInvestigators , actively involved pre transplant evaluation process . Patients Waiting List provide write consent receive ECD graft recruit trial . Subjects match 24 historical control patient receive similar cold store ECD graft . Subjects match know covariates include donor age , donation cardiac death , steatosis , warm cold ischemia time , recipient age , Model End-Stage Liver Disease ( MELD ) score disease etiology . Subjects noncritically ill , intensive care unit , MELD &lt; 35 order minimize variability outcome sick patient . All subject must provide write informed consent meet inclusion exclusion criterion . Subjects follow one year post transplantation , conjunction routine liver transplant followup appointment . Retention subject trial challenge , followup visit time point ( postoperative day 1 discharge date , 7 , 14 , 30 , 90 , 180 365 ) consistent standard care .</detailed_description>
	<mesh_term>Hypothermia</mesh_term>
	<criteria>Signed write inform IRB consent patient patient 's legally appoint representative . Be least 18 year age ; male female . Listed UNOS liver transplantation . Organ decline least one transplant center Extended criterion donor define : Presence hepatitis C antibody Donation Cardiac Death ( DCD ) Severe Hypernatremia : donor serum sodium &gt; 165 meq/L least 12 hour prior procurement Donor age â‰¥65 year Presence significant steatosis &gt; 25 % macrovesicular biopsy Evidence significant donor ischemic injury Current donor serum AST ALT &gt; 1000 IU/L Ischemic injury evidence prolonged hypotension , high pressor requirement and/or rise serum liver function test one test five time upper limit normal ( AST , ALT , Total Bilirubin ) Patients donor liver subject less 4 hour cold ischemia ( surgeon desire immediate implantation ) Patient hospitalize ICU time transplantation and/or physiologic MELD score &gt; 35 Dual organ recipient ABO incompatibility Retransplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>ECD liver transplant allograft</keyword>
	<keyword>Hypothermic machine perfusion</keyword>
	<keyword>Cold storage preservation</keyword>
	<keyword>liver transplant</keyword>
	<keyword>portable bypass system</keyword>
	<keyword>machine perfusion preservation</keyword>
	<keyword>extend criterion liver</keyword>
</DOC>